KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) Shares Outstanding (Diluted Average) (2019 - 2026)

Guardant Health's Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $125.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 2.14% to $125.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $125.4 million, a 2.14% increase, with the full-year FY2025 number at $125.4 million, up 2.14% from a year prior.
  • Shares Outstanding (Diluted Average) hit $125.4 million in Q4 2025 for Guardant Health, up from $124.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for GH hit a ceiling of $125.4 million in Q4 2025 and a floor of $101.0 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $111.7 million across 5 years, with a median of $109.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.8% in 2023 and later rose 18.55% in 2024.
  • Tracing GH's Shares Outstanding (Diluted Average) over 5 years: stood at $101.3 million in 2021, then grew by 0.85% to $102.2 million in 2022, then rose by 9.6% to $112.0 million in 2023, then grew by 9.61% to $122.7 million in 2024, then rose by 2.14% to $125.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for GH at $125.4 million in Q4 2025, $124.3 million in Q3 2025, and $124.0 million in Q2 2025.